Nanomedicines to Improve the Therapeutic Index of Drugs in Modern Drug Design
Conference Recording Jun 24, 2014
About the Speaker
Upon completion of her PhD into Oral Drug Delivery Systems to the Colon, in the Department of Pharmacy and Pharmaceutical Science, the University of Manchester, UK, Marianne joined ICI Pharmaceuticals in Cheshire (later to become Zeneca and then AstraZeneca). Since 2011, Marianne's role focused on exploiting drug delivery approaches to improve the therapeutic index of medicines and in particular, has worked closely with the Oncology teams to initiate a number of joint projects and collaborations in the Nanomedicine area. Marianne has authored a number of book chapters, research papers and patents in the pharmaceutical science arena and is keen to use her scientific knowledge and experience to improve therapies for patients.Abstract
This presentation will talk about context and challenges of therapeutic index in the pharmaceutical industry. The importance of therapeutic index improvement for Oncology and how nanoparticles can improve therapeutic index along with various case histories.